Human Metabolome Technologies announced ordinary profit of ¥0 million for the first quarter of the fiscal year ending June 2027 and maintained its full-year ordinary profit forecast at ¥220 million.
Human Metabolome Technologies announced that ordinary profit for the first quarter of the fiscal year ending June 2027 was ¥0 million. The article does not provide a breakdown of revenue or other profit and loss items associated with this result. As an earnings flash, it focuses mainly on the quarterly figure and the policy for the full-year forecast.
According to the performance forecast announced on the same day, full-year ordinary profit is expected to be ¥220 million, a 6.8% increase, with the previous forecast maintained. The company does not state the specific basis or assumptions underlying its performance outlook for the current fiscal year in the article.